Shares in Haemonetics (NYSE:HAE) have fallen nearly 10% today after the medical device maker posted fiscal year 2019 third quarter earnings that topped earnings per share estimates but missed sales consensus on Wall Street.
The Braintree, Mass.-based company posted profits of approximately $18.3 million, or 35ยข per share, on sales of approximately $247.4 million for the three months ended December 29, seeing a swing into the black on the bottom line while sales grew 5.7% compared with the same period during the previous year.
